RBC
BSX icon

Ronald Blue & Co’s Boston Scientific BSX Stock Holding History

Ronald Blue & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,595
Closed -$190K – 206
2015
Q3 		$190K Buy
11,595
+629
+6% +$10.8K 0.01% 280
2015
Q2 		$194K Buy
+10,966
New +$196K 0.01% 338

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ronald Blue & Co's BSX Position: Q4 2015 in Review

Ronald Blue & Co sold out of Boston Scientific (BSX) in Q4 2015, closing a stake of 11,595 shares — an estimated $190K sold.

Ronald Blue & Co first reported a position in BSX in Q2 2015 and held it in 2 quarters. The position peaked at $194K in Q2 2015. 502 funds tracked by Wall St. Rank hold BSX as of Q4 2015.

  • Ronald Blue & Co reported no remaining Boston Scientific position as of Q4 2015 after selling out during the quarter.
  • Ronald Blue & Co sold 11,595 Boston Scientific shares in Q4 2015, an estimated $190K.
  • Ronald Blue & Co first reported a position in Boston Scientific in Q2 2015 and held it in 2 quarters.
  • Ronald Blue & Co's Boston Scientific position peaked at $194K in Q2 2015.
  • 502 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2015.

Based on Ronald Blue & Co's 13F filing for Q4 2015, filed 11 Feb 2016.